Morphine and endomorphin-1 differently influence pronociceptin/orphanin FQ system in neuropathic rats

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 1, 2004, Pages 171-178

  Mika, Joanna ^a,b   Schäfer, Martin K H ^b   Obara, Ilona ^a   Weihe, Eberhard ^b   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Endomorphin 1; Morphine; Neuropathic pain; Nociceptin orphanin FQ; ORL1 receptor; Rat

Indexed keywords

ENDOMORPHIN 1; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN; NOCICEPTIN RECEPTOR ANTAGONIST; OPIOID RECEPTOR LIKE 1 RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; IN SITU HYBRIDIZATION; INJECTION; LUMBAR SPINAL CORD; MALE; MEASUREMENT; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD DORSAL HORN; SPINAL CORD VENTRAL HORN;

ANIMALS; MALE; MORPHINE; OLIGOPEPTIDES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, OPIOID; RNA, MESSENGER; SCIATIC NEUROPATHY;

LAMIINAE;

EID: 2442649947     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.03.005     Document Type: Article

References (49)

1. Abdulla F.A., Smith P.A. Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism. J. Neurosci. 17(22):1997;8721-8728
2. Andoh T., Itoh M., Kuraishi Y. Nociceptin/orphanin FQ gene expression in rat dorsal root ganglia induced by peripheral inflammation. NeuroReport. 8:1997;2793-2796
3. Angerer L.M., Cox K.H., Angerer R.C. Demonstration of tissue-specific gene expression by in situ hybridization. Methods Enzymol. 152:1987;649-661
4. Arner S., Myerson B.A. Lack of analgesic effect on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107
6. Bian D., Nichols M.L., Ossipov M.H., Lai J., Porreca F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. NeuroReport. 6:1995;1981-1984
7. Briscini L., Corradini L., Ongini E., Bertorelli R. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur. J. Pharmacol. 447:2002;59-65
8. Buzas B., Symes A.J., Cox B.M. Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. J. Neurochem. 72:1999;1882-1889
9. Celerier E., Laulin J., Larcher A., Le Moal M., Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 847(1):1999;18-25
10. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53(1):1994;55-63
11. Chen L., Gu Y., Huang L.Y. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J. Neurosci. 15:1995;4602-4611
12. Erb K., Liebel J.T., Tegeder I., Zeilhofer H.U., Brune K., Geisslinger G. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport. 8:1997;1967-1970
13. Friedman H.J., Jenm M.F., Changm J.K., Lee N.M., Loh H.H. Dynorphin, a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur. J. Pharmacol. 69:1981;357-360
14. Hao J.X., Xu I.S., Wiesenfeld-Hallin Z., Xu X.J. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain. 76:1998;385-393
15. Hedley L.R., Martin B., Waterbury L.D., Clarke D.E., Hunter J.C. A comparison of the action of mexiletine and morphine in rodent models of acute and chronic pain. Proc. West. Pharmacol. Soc. 8:1995;103-104
16. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719
17. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324:1997;153-160
18. Jia Y., Linden D.R., Serie J.R., Seybold V.S. Nociceptin/orphanin FQ binding increases in superficial lamina of the rat spinal cord during persistent peripheral inflammation. Neurosci. Lett. 250:1998;21-24
19. Kotlinska J., Wichmann J., Rafalski P., Talarek S., Dylag T., Silberring J. Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence. NeuroReport. 14(4):2003;601-604
20. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M.H., Porreca F., et al. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 72:1997;253-260
21. Liebel J.T., Swandulla D., Zeilhofer H.U. Modulation of excitatory synaptic transmission by nociceptin/orphanin FQ in superficial dorsal horn neurones of the neonatal rat spinal cord. Br. J. Pharmacol. 121:1997;425-432
22. Lin B., Waterman R., Lippton H. Nociceptin receptor activation produces nitric oxide-mediated systemic hypotension. Life Sci. 66(6):2000;PL99-PL104
23. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 25:1984;7035-7056
24. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15
25. Minami T., Okuda-Ashitaka E., Mori H., Sakimura K., Watanabe M., Mishina M., et al. Characterization of nociceptin/orphanin FQ-induced pain responses in conscious mice: neonatal capsaicin treatment and N-methyl-D-aspartate receptor GluRepsilon subunit knockout mice. Neuroscience. 97(1):2000;133-142
26. Mollereau C., Simons M.J., Soularue P., Liners F., Vassart G., Meunier J.C., et al. Structure, tissue distribution, and chromosomal localization of the prepronociceptin/orphanin FQ gene. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8666-8670
27. Narita M., Mizoguchi H., Narita M., Sora I., Uhl G.R., Tseng L.F. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Br. J. Pharmacol. 126:1999;451-456
28. Narita M., Mizoguchi H., Khotib J., Suzuki M., Ozaki S., Yajima Y., et al. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla. Neurosci. Lett. 331:2002;5-8
29. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain. 69:1997;317-322
30. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., et al. Nocistatin, a peptide that blocks nociceptin/orphanin FQ action in pain transmission. Nature. 392:1998;286-289
31. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199:1995;1-4
32. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199:1995;87-90
33. Ossipov M.H., Kovelowski C.J., Wheeler-Aceto H., Cowan A., Hunter J.C., Lai J., et al. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J. Pharmacol. Exp. Ther. 277:1996;784-788
34. Przewlocka B., Mika J., Labuz D., Toth G., Przewlocki R. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur. J. Pharmacol. 367:1999;189-196
35. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794
36. Schafer M.K., Day R., Cullinan W.E., Chretien M., Seidah N.G., Watson S.J. Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J. Neurosci. 13:1993;1258-1279
37. Twycross R.G. Morphine and diamorphine in the terminally ill patient. Acta Anaesthesiol. Scand. 74:1982;128-134
38. Ueda H., Inoue M., Takeshima H., Iwasawa Y. Enhanced spinal ORL1 receptor expression develops morphine tolerance and dependence. J. Neurosci. 20:2000;7640-7647
39. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., et al. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain. 68:1996;275-281
40. Vanderah T.W., Ossipov M.H., Lai J., Malan T.P. Jr., Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain. 92:2001;5-9
41. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin/orphanin FQ or antinociceptin/orphanin FQ: potent spinal antinociceptive effect of orphanin FQ/nociceptin/orphanin FQ in the rat. NeuroReport. 7:1996;2092-2094
42. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036
43. Yaksh T.L., Pogrel J.W., Lee Y.W., Chaplan S.R. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther. 272:1995;207-214
44. Yamamoto T., Nozaki-Taguchi N. Effects of intrathecally administered nociceptin/orphanin FQ, an opioid receptor-like1 receptor agonist, and N-methyl-D-aspartate receptor antagonists on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat. Anesthesiology. 87:1997;1145-1152
45. Yamamoto T., Nozaki-Taguchi N., Kimura S. Analgesic effect of intrathecally administered nociceptin/orphanin FQ, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience. 81:1997;249-254
46. Yamamoto T., Nozaki-Taguchi N., Kimura S. Effects of intrathecally administered nociceptin/orphanin FQ, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carageenan injection into the rat paw. Brain Res. 754:1997;329-332
47. Yamamoto T., Nozaki-Taguchi N., Kimura S. Effects of intrathecally administered nociceptin/orphanin FQ, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci. Lett. 224:1997;107-110
48. Zadina J.E., Hackler L., Lin-Jun G., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502
49. Zhu C.B., Cao X.D., Xu S.F., Wu G.C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci. Lett. 235:1997;37-40